J&J in $1 billion deal to bolster prostate-cancer focus
(Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/WvuPZlhN_3U/story01.htm
No comments:
Post a Comment